Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.

Li X, Brown N, Chau AS, L?pez-Ribot JL, Ruesga MT, Quindos G, Mendrick CA, Hare RS, Loebenberg D, DiDomenico B, McNicholas PM. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. J Antimicrob Chemother. 2004 Jan; 53(1):74-80.

View in: PubMed

subject areas

AIDS-Related Opportunistic Infections
Antifungal Agents
Candida albicans
Candidiasis, Oral
Drug Resistance, Fungal
Genes, Viral
HIV Infections
Humans
Microbial Sensitivity Tests
Mutation
Triazoles

authors with profiles

Jose L. Lopez-Ribot

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support